Literature DB >> 18196985

Vitamin K intake and atherosclerosis.

Arja T Erkkilä1, Sarah L Booth.   

Abstract

PURPOSE OF REVIEW: It has been hypothesized that insufficient intake of vitamin K may increase soft-tissue calcification owing to impaired gamma-carboxylation of the vitamin K-dependent protein matrix gamma-carboxyglutamic acid. The evidence to support this putative role of vitamin K intake in atherosclerosis is reviewed. RECENT
FINDINGS: In animal models, multiple forms of vitamin K have been shown to reverse the arterial calcification created by vitamin K antagonists. The human data, however, are less consistent. Phylloquinone, the primary dietary form, has not been associated consistently with the risk of cardiovascular diseases. High menaquinone intake may be associated with lower risk of coronary heart disease mortality, but this needs to be confirmed.
SUMMARY: The role of vitamin K in calcification remains controversial. Although biologically plausible, results from the human studies have not consistently supported this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18196985     DOI: 10.1097/MOL.0b013e3282f1c57f

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  12 in total

1.  Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.

Authors:  M Kyla Shea; Kathryn Barger; Sarah L Booth; Gregory Matuszek; Mary Cushman; Emelia J Benjamin; Stephen B Kritchevsky; Daniel E Weiner
Journal:  Am J Clin Nutr       Date:  2020-06-01       Impact factor: 7.045

2.  Oral anticoagulation and VKORC1 polymorphism in patients with a mechanical heart prosthesis: a 6-year follow-up.

Authors:  Carlo Giansante; Nicola Fiotti; Nicola Altamura; Paola Pitacco; Lara Consoloni; Sabino Scardi; Carmine Mazzone; Gabriele Grassi; Claudio Pandullo; Andrea Di Lenarda
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

Review 3.  Multifaceted interaction of bone, muscle, lifestyle interventions and metabolic and cardiovascular disease: role of osteocalcin.

Authors:  I Levinger; T C Brennan-Speranza; A Zulli; L Parker; X Lin; J R Lewis; B B Yeap
Journal:  Osteoporos Int       Date:  2017-03-13       Impact factor: 4.507

Review 4.  The role of osteocalcin in human glucose metabolism: marker or mediator?

Authors:  Sarah L Booth; Amanda Centi; Steven R Smith; Caren Gundberg
Journal:  Nat Rev Endocrinol       Date:  2012-11-13       Impact factor: 43.330

Review 5.  Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements.

Authors:  Barbara Walther; J Philip Karl; Sarah L Booth; Patrick Boyaval
Journal:  Adv Nutr       Date:  2013-07-01       Impact factor: 8.701

6.  A cardiovascular phenotype in warfarin-resistant Vkorc1 mutant rats.

Authors:  Michael H Kohn; Roger E Price; Hans-Joachim Pelz
Journal:  Artery Res       Date:  2008-11       Impact factor: 0.597

7.  Vitamin K supplementation and progression of coronary artery calcium in older men and women.

Authors:  M Kyla Shea; Christopher J O'Donnell; Udo Hoffmann; Gerard E Dallal; Bess Dawson-Hughes; José M Ordovas; Paul A Price; Matthew K Williamson; Sarah L Booth
Journal:  Am J Clin Nutr       Date:  2009-04-22       Impact factor: 7.045

8.  Vitamin K epoxide reductase complex subunit 1 (Vkorc1) haplotype diversity in mouse priority strains.

Authors:  Ying Song; Nicole Vera; Michael H Kohn
Journal:  BMC Res Notes       Date:  2008-12-01

Review 9.  Vitamin K for the primary prevention of cardiovascular disease.

Authors:  Louise Hartley; Christine Clar; Obadah Ghannam; Nadine Flowers; Saverio Stranges; Karen Rees
Journal:  Cochrane Database Syst Rev       Date:  2015-09-21

10.  Intake of dietary phylloquinone and menaquinones and risk of stroke.

Authors:  Linda E T Vissers; Geertje W Dalmeijer; Jolanda M A Boer; W M Monique Verschuren; Yvonne T van der Schouw; Joline W J Beulens
Journal:  J Am Heart Assoc       Date:  2013-12-10       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.